Semin Reprod Med 2010; 28(5): 422-425
DOI: 10.1055/s-0030-1262901
© Thieme Medical Publishers

Skeletal Implications of Reproductive Aging

Ruth Freeman1
  • 1Medical Center, Albert Einstein College of Medicine, Bronx, New York
Further Information

Publication History

Publication Date:
23 September 2010 (online)

ABSTRACT

The skeleton's density (mineral content and strength) is due to genetics (~60%), nutrition (~20%), and sex hormones (20%). The last factor increases bone density at puberty, mostly due to estrogen production. During reproductive aging as the ovaries lose most of their follicles, estrogen production declines. Bone collagen and mineral content decreases as the total cyclic estrogen production declines until the postmenopausal phase of life, at which point the 20% gained at puberty has been lost. This process starts before menses have changed, when fertility starts to be reduced. The most rapid loss of bone density occurs after actual menopause. Thereafter the rate of bone substance loss slows to the same rate as seen in aging men and is likely related to aging itself. In conclusion, decline in estrogen production is a major cause of bone mineral decrease.

REFERENCES

  • 1 Bailey D A, Martin A D, McKay H A, Whiting S, Mirwald R. Calcium accretion in girls and boys during puberty: a longitudinal analysis.  J Bone Miner Res. 2000;  15(11) 2245-2250
  • 2 Rodin A, Murby B, Smith M A et al. Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women.  Bone. 1990;  11(1) 1-5
  • 3 Mazess R B, Barden H S. Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills.  Am J Clin Nutr. 1991;  53(1) 132-142
  • 4 Riggs B L, Wahner H W, Seeman E et al. Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes.  J Clin Invest. 1982;  70(4) 716-723
  • 5 Makovey J, Nguyen T V, Naganathan V, Wark J D, Sambrook P N. Genetic effects on bone loss in peri- and postmenopausal women: a longitudinal twin study.  J Bone Miner Res. 2007;  22(11) 1773-1780
  • 6 Baudoin C, Cohen-Solal M E, Beaudreuil J, De Vernejoul M C. Genetic and environmental factors affect bone density variances of families of men and women with osteoporosis.  J Clin Endocrinol Metab. 2002;  87(5) 2053-2059
  • 7 Pocock N A, Eisman J A, Hopper J L, Yeates M G, Sambrook P N, Eberl S. Genetic determinants of bone mass in adults. A twin study.  J Clin Invest. 1987;  80(3) 706-710
  • 8 Frank G R. The role of estrogen in pubertal skeletal physiology: epiphyseal maturation and mineralization of the skeleton.  Acta Paediatr. 1995;  84(6) 627-630
  • 9 Richelson L S, Wahner H W, Melton III L J, Riggs B L. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.  N Engl J Med. 1984;  311(20) 1273-1275
  • 10 Matkovic V, Jelic T, Wardlaw G M et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model.  J Clin Invest. 1994;  93(2) 799-808
  • 11 Hale G E, Zhao X, Hughes C L, Burger H G, Robertson D M, Fraser I S. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system.  J Clin Endocrinol Metab. 2007;  92(8) 3060-3067
  • 12 Burger H G, Hale G E, Dennerstein L, Robertson D M. Cycle and hormone changes during perimenopause: the key role of ovarian function.  Menopause. 2008;  15(4 Pt 1) 603-612
  • 13 Sherman B M, Korenman S G. Hormonal characteristics of the human menstrual cycle throughout reproductive life.  J Clin Invest. 1975;  55(4) 699-706
  • 14 Soules M R, Sherman S, Parrott E et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW).  Fertil Steril. 2001;  76(5) 874-878
  • 15 Pal L, Norian J, Zeitlian G, Bevilacqua K, Freeman R, Santoro N. Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density.  Fertil Steril. 2008;  90(5) 1626-1634
  • 16 Sowers M R, Zheng H, McConnell D, Nan B, Harlow S, Randolph Jr J F. Follicle stimulating hormone and its rate of change in defining menopause transition stages.  J Clin Endocrinol Metab. 2008;  93(10) 3958-3964
  • 17 Melton III L J, Hesdorffer D C, Malkasian G D, Atkinson E J, Brinton L A, O'Fallon W M. Long-term fracture risk among infertile women: a population-based cohort study.  J Womens Health Gend Based Med. 2001;  10(3) 289-297
  • 18 Hui S L, Perkins A J, Zhou L et al. Bone loss at the femoral neck in premenopausal white women: effects of weight change and sex-hormone levels.  J Clin Endocrinol Metab. 2002;  87(4) 1539-1543
  • 19 Sherman B M, West J H, Korenman S G. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.  J Clin Endocrinol Metab. 1976;  42(4) 629-636
  • 20 Santoro N, Lasley B, McConnell D et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study.  J Clin Endocrinol Metab. 2004;  89(6) 2622-2631
  • 21 Sirola J, Kröger H, Honkanen R OSTPRE Study Group et al. Factors affecting bone loss around menopause in women without HRT: a prospective study.  Maturitas. 2003;  45(3) 159-167
  • 22 Bainbridge K E, Sowers M, Lin X, Harlow S D. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women.  Osteoporos Int. 2004;  15(6) 439-446
  • 23 Sowers M, Crutchfield M, Bandekar R et al. Bone mineral density and its change in pre-and perimenopausal white women: the Michigan Bone Health Study.  J Bone Miner Res. 1998;  13(7) 1134-1140
  • 24 Qin L, Au S K, Leung P C et al. Baseline BMD and bone loss at distal radius measured by peripheral quantitative computed tomography in peri- and postmenopausal Hong Kong Chinese women.  Osteoporos Int. 2002;  13(12) 962-970
  • 25 Ho S C, Chan S G, Yip Y B, Chan C S, Woo J L, Sham A. Change in bone mineral density and its determinants in pre- and perimenopausal Chinese women: the Hong Kong Perimenopausal Women Osteoporosis Study.  Osteoporos Int. 2008;  19(12) 1785-1796
  • 26 Seeman E. From density to structure: growing up and growing old on the surfaces of bone.  J Bone Miner Res. 1997;  12(4) 509-521
  • 27 Seifert-Klauss V, Link T, Heumann C et al. Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study.  Maturitas. 2006;  55(4) 317-324
  • 28 Macdonald H M, New S A, Campbell M K, Reid D M. Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women.  Osteoporos Int. 2005;  16(2) 163-171
  • 29 Syed F, Khosla S. Mechanisms of sex steroid effects on bone.  Biochem Biophys Res Commun. 2005;  328(3) 688-696
  • 30 Kato Y, Ishikawa-Takata K, Yasaku K, Okawa Y, Kawakami O, Ohta T. Changes in metacarpal bone mineral density with age and menopause using computed X-ray densitometry in Japanese women: cross-sectional and longitudinal study.  Ann Hum Biol. 2005;  32(6) 760-772
  • 31 Riggs B L, Melton III L J. The prevention and treatment of osteoporosis.  N Engl J Med. 1992;  327(9) 620-627
  • 32 Riggs B L, Khosla S, Melton III L J. Sex steroids and the construction and conservation of the adult skeleton.  Endocr Rev. 2002;  23(3) 279-302
  • 33 Bieglmayer C, Kudlacek S. The bone marker plot: an innovative method to assess bone turnover in women.  Eur J Clin Invest. 2009;  39(3) 230-238
  • 34 Christiansen C, Christensen M S, Larsen N E, Transbøl I B. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.  J Clin Endocrinol Metab. 1982;  55(6) 1124-1130
  • 35 Gallagher C M, Moonga B S, Kovach J S. Cadmium, follicle-stimulating hormone, and effects on bone in women age 42–60 years, NHANES III.  Environ Res. 2010;  110(1) 105-111
  • 36 Castelo-Branco C, Duran M, Balasch J. Follicle-stimulating hormone does not directly regulate bone mass in human beings: evidence from nature.  Fertility Sterility. 2008;  90(6) 2211-2216

Ruth FreemanM.D. 

Professor of Medicine, Professor of Obstetrics Gynecology and Women's Health, Director of Bone Densitometry Unit

Montefiore Medical Center, Albert Einstein College of Medicine, 1695 Eastchester Road, Bronx, New York 10461

Email: rfreeman@montefiore.org

    >